Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, announces that, following an exercise of options, application has been made to the London Stock Exchange for the admission of 20,000 new Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings will commence in the new Ordinary Shares on or around 31 October 2018.
Subsequent to admission there will be 60,057,161 Ordinary Shares of 20p each in issue with voting rights. No shares are held in treasury.
30 October 2018
Enquiries:
Animalcare Group plc
Chris Brewster, Chief Financial Officer
Tel: 01904 487 687
Panmure Gordon (UK) Ltd (Nominated Adviser & Broker)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.